Clinigen
This role serves as the front-door integrity control for Clinigen's third-party ecosystem, ensuring that suppliers and service partners are properly vetted, monitored, and controlled to mitigate ABAC, fraud, sanctions, and reputational risks. The position is accountable for managing the end-to-end third-party due diligence lifecycle, including risk assessment, sanctions screening, and ongoing monitoring, while maintaining the TPRM operating model and NAVEX RiskRate platform. The role involves producing risk intelligence, enabling stakeholder adoption of compliance processes, and ensuring defensible decision-making aligned with global regulatory expectations.
Headquarters
London, England, United Kingdom
Company Size
1001-5000 employees
Founded
2010
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Clinigen.
Clinigen didn’t post a salary, so this is our estimate from similar listings.
44% below the average for this role